Ligand profile
ZINC7525
Virtual-screening candidate from ZINC.
Bound to: KP13_00107 — 4-hydroxybenzoate transporter
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC7525- UniProt (similar protein)
P0A0J7- Tanimoto
- 1.000
- Target protein
- KP13_00107
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 39.7
- −1 ≤ LogP ≤ 5 3.33
- MW ≤ 500 Da 329.4
- LogP ≤ 5 3.33
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 39.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Fc1ccc([C@H]2CCNC[C@@H]2COc2ccc3c(c2)OCO3)cc1Fc1ccc([C@H]2CCNC[C@@H]2COc2ccc3c(c2)OCO3)cc1
InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m1/s1InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m1/s1
AHOUBRCZNHFOSL-RHSMWYFYSA-NAHOUBRCZNHFOSL-RHSMWYFYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 8PR
- Homolog
- P0A0J7
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC7525 →
- ZINC ZINC20 ZINC7525 →
- UniProt UniProt P0A0J7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC7525”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00107.
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).